Anti-genotoxicity of galangin as a cancer chemopreventive agent candidate

Mutation Research - Reviews in Mutation Research

Volumn 488, Issue 2, 2001, Pages 135-150

  Heo, Moon Y ^a   Sohn, Su J ^b   Au, William W ^c  

^a Kangwon National University   (South Korea)

^b National Institute of Toxicological Research   (South Korea)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Anti genotoxicity; Anti oxidative activity; Cancer chemopreventive agent; Enzyme modulation; Flavonoid; Galangin

Indexed keywords

ALKYLATING AGENT; ANTHRACENE DERIVATIVE; AROMATASE; BENZO[A]PYRENE; BLEOMYCIN; CARBONYL REDUCTASE; CARCINOGEN; CYCLOOXYGENASE 2; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; DYE; ENZYME; ETHOXYRESORUFIN DEETHYLASE; FLAVANOID; GALANGIN; METHOXYRESORUFIN O DEMETHYLASE; METHYLNITROSOUREA; MITOMYCIN C; MUTAGENIC AGENT; N (2 FLUORENYL)ACETAMIDE; PHENYLSULFOTRANSFERASE; PLANT EXTRACT; POLYCYCLIC AROMATIC HYDROCARBON; POLYPHENOL DERIVATIVE; PROPOLIS; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); SCAVENGER; UNCLASSIFIED DRUG;

CANCER CHEMOTHERAPY; CANCER PREVENTION; CHEMOPROPHYLAXIS; CHROMOSOME ABERRATION; DNA ADDUCT; DRUG ACTIVITY; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; GENE MUTATION; GENOTOXICITY; HUMAN; MICRONUCLEUS; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION;

ALKYLATING AGENTS; ANIMALS; ANTICARCINOGENIC AGENTS; ANTIMUTAGENIC AGENTS; ANTIOXIDANTS; CARCINOGENS; CELL DIVISION; CYCLOOXYGENASE 2; DNA ADDUCTS; FLAVONOIDS; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; NEOPLASMS; POLYCYCLIC HYDROCARBONS, AROMATIC; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RADIATION-PROTECTIVE AGENTS; STRUCTURE-ACTIVITY RELATIONSHIP;

ALPINIA OFFICINARUM; PROPOLIS;

EID: 0035022576     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5742(01)00054-0     Document Type: Review

References (132)

1. Kelloff G.J. Perspectives on cancer chemoprevention research and drug development. Adv. Cancer Res. 78:1999;199-334.
2. Shureiqi I., Reddy P., Brenner D.E. Chemoprevention: general perspective. Crit. Rev. Oncol. Hematol. 33:2000;157-167.
3. Fisher B., Costantino J.P., Wickerham D.L., Redmond C.K., Kavanah M., Cronin W.M., Vogel V., Robidoux A., Dimitrov N., Atkins J., Daly M., Wieand S., Tan-Chiu E., Ford L., Wolmark N. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J. Natl. Cancer Instit. 90:1998;1371-1388.
4. Heinonen O.P., Albanes D., Virtamo J., Taylor P.R., Huttunen J.K., Hartman A.M., Haapakoski J., Malila N., Rautalahti M., Ripatti S., Maenpaa H., Teerenhovi L., Koss L., Virolainen M., Edwards B.K. Prostate cancer and supplementation with α-tocopherol and β-carotene: incidence and mortality in a controlled trial. J. Natl. Cancer Instit. 90:1998;440-446.
5. Kelloff G.J., Sigman C.C., Greenwald P. Cancer chemoprevention: progress and promise. Eur. J. Cancer. 35:1999;2031-2038.
6. E. Middleton Jr., C. Kandaswami, The impact of plant flavonoids on mammalian biology: implications for immunity, inflammation and cancer, in: J.B. Harborne (Ed.), The Flavonoids Advance in Research Since 1986, 1st Edition, Chapman & Hall, London, 1994, pp. 619-652.
7. Kuhnau J. The flavonoids, a class of semi-essential food components: their role in human nutrition. World Rev. Nutr. Diet. 24:1976;117-191.
8. Hertog M.G.L., Hollman P.C.H., Katan M.B., Kromhout D. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. Nutr. Cancer. 20:1993;21-29.
9. Peterson J., Dwyer J. Flavonoids: dietary occurrence and biochemical activity. Nutr. Res. 18:1998;1995-2018.
10. Stavric B. Antimutagens and anticarcinogens in foods. Food Chem. Toxicol. 32:1994;79-90.
11. Hollman P.C., Katan M.B. Dietary flavonoids: intake, health effects and bioavailability. Food Chem. Toxicol. 37:1999;937-942.
12. Park Y.K., Koo M.H., Sato H.H., Contado J.L. Survey of some components of propolis which were collected by Apis mellifera in Brazil. Arch. Biol. Technol. 38:1995;1253-1259.
13. Wall M.E., Wani M.C., Manikumar G., Abraham P., Taylor H., Hughes T.J., Warner J., McGiveney R. Plant antimutagenic agents. 2. Flavonoids. J. Natl. Prod. 51:1988;1084-1091.
14. Heo M.Y., Lee J.H., Sohn S.J., Au W.W. Anticlastogenic effects of galangin against mitomycin C-induced micronuclei in reticulocytes of mice. Mutat. Res. 360:1996;37-41.
15. 4-induced microsomal lipid peroxidation. Experientia. 47:1991;195-199.
16. Imamura Y., Migita T., Uriu Y., Otagiri M., Okawara T. Inhibitory effects of flavonoids on rabbit heart carbonyl reductase. J. Biochem. Tokyo. 127:2000;653-658.
17. Shih H., Pickwell G.V., Quattrochi L.C. Differential effects of flavonoid compounds on tumor promoter-induced activation of the human CYP1A2 enhancer. Arch. Biochem. Biophys. 373:2000;287-294.
18. Francis A.R., Shetty T.K., Bhattacharya R.K. Modulating effect of plant flavonoids on the mutagenicity of N-methyl-N-nitro-N-nitrosoguanidine. Carcinogenesis. 10:1989;1953-1955.
19. Sohn S.J., Kim J.H., Kim Y.J., Huh I.H., Heo M.Y. Inhibition of N-methyl-N-nitrosourea-induced sister-chromatid exchange and DNA methylation by galangin. Yakhak Hoeji. 39:1995;94-101.
20. Sohn S.J., Huh I.H., Au W.W., Heo M.Y. Antigenotoxicity of galangin against N-methyl-N-nitrosourea. Mutat. Res. 402:1998;231-236.
21. Heo M.Y., Yu K.S., Kim K.H., Kim H.P., Au W.W. Anticlastogenic effect of flavonoids against mutagen-induced micronuclei in mice. Mutat. Res. 284:1992;243-249.
22. Wattenerg L.W., Leong J.L. Inhibition of carcinogenic action of benzo[a]pyrene by flavones. Cancer Res. 30:1970;1922-1925.
23. Huang M.T., Wood A.W., Newmark H.L., Sayer J.M., Yagi H., Jerina D.M., Conney A.H. Inhibition of the mutagenicity of bay region epoxide of polycyclic aromatic hydrocarbons by plant flavonoids. Carcinogenesis. 4:1983;1631-1637.
24. Varanda E.A., Monti R., Tavares D.C. Inhibitory effect of propolis and bee venom on the mutagenicity of some direct- and indirect-acting mutagens. Teratog. Carcinog. Mutagen. 19:1999;403-413.
25. Shimoi K., Masuda S., Shen B., Furugori M., Kinae N. Radioprotective effects of antioxidative plant flavonoids in mice. Mutat. Res. 350:1996;153-161.
26. Heo M.Y., Lee S.J., Kwon C.H., Kim S.W., Sohn D.H., Au W.W. Anticlastogenic effects of galangin against bleomycin-induced chromosomal aberrations in mouse spleen lymphocytes. Mutat. Res. 311:1994;225-229.
27. Heo M.Y., Lee J.H., Sohn S.J., Au W.W. Anticlastogenic effects of galangin against mitomycin C-induced micronuclei in reticulocytes of mice. Mutat. Res. 360:1992;37-41.
28. Krikováa L., Nagyb M., Polónyia J., Ebringera L. The effect of flavonoids on ofloxacin-induced mutagenicity in Euglena gracilis. Mutat. Res. 416:1998;85-92.
29. Umezawa N., Arakane K., Ryu A., Mashiko S., Hirobe M., Nagano T. Participation of reactive oxygen species in phototoxicity induced by quinolone antibacterial agents. Arch. Biochem. Biophys. 342:1997;275-281.
30. Ebringer L., Dobias J., Krajovi J., Polónyi J., Kriková L., Lahitová N. Antimutagens reduce ofloxacin-induced bleaching in Euglena gracilis. Mutat. Res. 359:1996;85-93.
31. Kuo S.M. Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells. Cancer Lett. 110:1996;41-48.
32. Castillo M.H., Perkins E., Campbell J.H., Doerr R., Hassett J.M., Kandaswami C., Middleton E. Jr. The effects of the bioflavonoid quercetin on squamous cell carcinoma of head and neck origin. Am. J. Surg. 158:1989;351-355.
33. Yoshida M., Sakai T., Hosokawa N., Marui N., Matsumoto K., Fujioka A., Nishino H., Aoike A. The effect of quercetin on cell cycle progression and growth of human gastric cancer cells. FEBS Lett. 260:1990;10-13.
34. Yanagihara K., Ito A., Toge T., Numoto M. Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract. Cancer Res. 53:1993;5815-5821.
35. Kuo S.M., Morehouse H.F. Jr., Lin C.P. Effect of antiproliferative flavonoids on ascorbic acid accumulation in human colon adenocarcinoma cells. Cancer Lett. 116:1997;131-137.
36. Graefe E.U., Derendorf H., Veit M. Pharmacokinetics and bioavailability of the flavonol quercetin in humans. Int. J. Clin. Pharmacol. Ther. 37:1999;219-233.
37. Mahmoud N.N., Carothers A.M., Grunberger D., Bilinski R.T., Churchill M.R., Martucci C., Newmark H.L., Bertagnolli M.M. Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis. Carcinogenesis. 21:2000;921-927.
38. Levy J., Teuerstein I., Marbach M., Radian S., Sharoni Y. Tyrosine protein kinase activity in the DMBA-induced rat mammary tumor: inhibition by quercetin. Biochem. Biophys. Res. Commun. 123:1984;1227-1233.
39. Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoh N., Shibuya M., Fukami Y. Genistein a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262:1987;5592-5595.
40. Ferriola P.C., Cody V., Middleton E. Jr. Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure-activity relationships. Biochem. Pharmacol. 38:1989;1617-1624.
41. Wenzel U., Kuntz S., Brendel M.D., Daniel H. Dietary flavone is a potent apoptosis inducer in human colon carcinoma cells. Cancer Res. 60:2000;3823-3831.
42. So F.V., Guthrie N., Chambers A.F., Carroll K.K. Inhibition of proliferation of estrogen receptor-positive MCF-7 human breast cancer cells by flavonoids in the presence and absence of excess estrogen. Cancer Lett. 112:1997;127-133.
43. Quadri S.A., Qadri A.N., Hahn M.E., Mann K.K., Sherr D.H. The bioflavonoid galangin blocks aryl hydrocarbon receptor activation and polycyclic aromatic hydrocarbon-induced pre-B-cell apoptosis. Mol. Pharmacol. 58:2000;515-525.
44. Nagao M., Morita N., Yahagi T., Shimizu M., Kuroyanagi M., Fukuoka M., Yoshihira K., Natori S., Fujino T., Sugimura T. Mutagenicities of 61 flavonoids and 11 related compounds. Environ. Mutagen. 3:1981;401-419.
45. Ito N., Hagiwara A., Tamano S., Kagawa M., Shibata M.A., Kurata Y., Fukushima S. Lack of carcinogenicity of quercetin in F344/DuCrj rats. Jpn. J. Cancer Res. 80:1989;317-325.
46. NTP Technical Report No. 409 on the Toxicology and Carcinogenesis, Studies of Quercetin in F344/N rats, NIH Publication No. 91-3140, US Department of Health and Human Services, Public Health Service, National Toxicology Program, Research Triangle Park, NC, 1991.
47. MacGregor J.T., Jurd L. Mutagenicity of plant flavonoids: structural requirements for mutagenic activity in Salmonella typhimurium. Mutat. Res. 54:1978;297-309.
48. Carver J.H., Carrano A.V., MacGregor J.T. Genetic effects of the flavonols quercetin, kaempferol, and galangin on Chinese hamster ovary cells in vitro. Mutat. Res. 113:1983;45-60.
49. Brown J.P., Dietrich P.S. Mutagenicity of plant flavonols in the Salmonella/mammalian microsome test: activation of flavonol glycosides by mixed glycosidases from rat cecal bacteria and other sources. Mutat. Res. 66:1979;223-240.
50. Silva I.D., Rodrigues A.S., Gaspar J., Laires A., Rueff J. Metabolism of galangin by rat cytochromes P450: relevance to the genotoxicity of galangin. Mutat. Res. 393:1997;247-257.
51. Ogawa S., Hirayama T., Sumida Y., Tokuda M., Hirai K., Fukui S. Enhancement of the mutagenicity of 2-acetylaminofluorene by flavonoids and the structural requirements. Mutat. Res. 190:1987;107-112.
52. Silva I.D., Gaspar J., da Costa G.G., Rodrigues A.S., Laires A., Rueff J. Chemical features of flavonols affecting their genotoxicity. Potential implications in their use as therapeutical agents. Chem. Biol. Interact. 124:2000;29-51.
53. MacGregor J.T., Wehr C.M., Manners G.D., Jurd L., Minkler J.L., Carrano A.V. In vivo exposure to plant flavonols. Influence on frequencies of micronuclei in mouse erythrocytes and sister-chromatid exchange in rabbit lymphocytes. Mutat. Res. 124:1983;255-270.
54. Said Ahmad M., Fazal F., Rahman A., Hadi S.M., Parish J.H. Activities of flavonoids for the cleavage of DNA in the presence of Cu(II): correlation with generation of active oxygen species. Carcinogenesis. 13:1992;605-608.
55. Yamashita N., Tanemura H., Kawanishi S. Mechanism of oxidative DNA damage induced by quercetin in the presence of Cu(II). Mutat. Res. 425:1999;107-115.
56. Sahu S.C., Gray G.C. Lipid peroxidation and DNA damage induced by morin and naringenin in isolated rat liver nuclei. Food Chem. Toxicol. 35:1997;443-447.
57. Heo M.Y., Yang H.E. Antigenotoxicity of quercetin and its glycosides against oxidative DNA damage. Environ. Mol. Mutagen. 35(Suppl. 31):2000;81.
58. Block G., Patterson B., Subar A. Fruits, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr. Cancer. 18:1992;1-29.
59. Wattenberg L.W. Inhibition of carcinogenesis by minor dietary compounds. Cancer Res. 52:1992;2085-2091.
60. J. Digiovanni, Inhibition of chemical carcinogenesis, in: C.S. Cooper, P.L. Grover (Eds.), Chemical Carcinogenesis and Mutagenesis, Springer, Berlin, 1999, pp. 159-253.
61. Gandhi R.K., Khanduja K.L. Impact of quercetin composition on phase I and phase II drug metabolizing enzymes in mice. J. Clin. Biochem. Nutr. 14:1993;107-112.
62. Mukhtar H., Das M., Khan W.A., Bik D.P. Exceptional activity of tannic acid among naturally occurring plant phenols in protecting against 7,12-dimethybenz[a]anthracene-, benzo[a]pyrene-, 3-methylcholanthrene-, and N-methyl-N-nitrosourea-induced skin tumorigenesis in mice. Cancer Res. 48:1988;2361-2365.
63. Guengerich F.P. Roles of cytochrome P450 enzymes in chemical carcinogenesis and cancer chemotherapy. Cancer Res. 48:1988;2946-2954.
64. Tsyrlov I.B., Mikhailenko V.M., Gelboin H.V. Isozyme- and species-specific susceptibility of cDNA-expressed CYP1A P450s to different flavonoids. Biochim. Biophys. Acta. 1205:1994;325-335.
65. Havsteen B. Flavonoids, a class of natural products of high pharmacological potency. Biochem. Pharmacol. 32:1983;1141-1148.
66. Lasker J.M., Huang M.T., Conney A.H. In vitro and in vivo activation of oxidative drug metabolism by flavonoids. J. Pharmacol. Exp. Ther. 229:1984;162-170.
67. Friedman F.K., West D., Sugimura T., Gelboin H.V. Flavone modulators of rat hepatic aryl hydrocarbon hydroxylase. Pharmacology. 31:1985;203-207.
68. Trela B.A., Carlson G.P. Effect of flavonone on mixed-function oxidase and conjugation reactions in rats. Xenobiotica. 17:1987;11-16.
69. Obermeier M.T., White R.E., Yang C.S. Effects of bioflavonoids on hepatic P450 activities. Xenobiotica. 25:1995;575-584.
70. Guengerich F.P. Oxidation of toxic and carcinogenic chemicals by human cytochrome P450 enzymes. Chem. Res. Toxicol. 4:1991;391-407.
71. Brosen K. Drug interactions and the cytochrome P450 system. The role of cytochrome P450 1A2. Clin. Pharmacokinet. 29(Suppl 1):1995;20-25.
72. Wattenberg L.W. Chemoprevention of cancer. Cancer Res. 45:1985;1-8.
73. 1 metabolism in human liver microsomes by naturally occurring flavonoids. Cancer Res. 41:1981;67-72.
74. Ciolino H.P., Yeh G.C. The flavonoid galangin is an inhibitor of CYP1A1 activity and an agonist/antagonist of the aryl hydrocarbon receptor. Br. J. Cancer. 79:1999;1340-1346.
75. Dai R., Zhai S., Wei X., Pincus M.R., Vestal R.E., Friedman F.K. Inhibition of human cytochrome P450 1A2 by flavones: a molecular modeling study. J. Protein Chem. 17:1998;643-650.
76. Zhai S., Dai R., Wei X., Friedman F.K., Vestal R.E. Inhibition of methoxyresorufin demethylase activity by flavonoids in human liver microsomes. Life Sci. 63:1998;PL119-123.
77. Zhai S., Dai R., Friedman F.K., Vestal R.E. Comparative inhibition of human cytochromes P450 1A1 and 1A2 by flavonoids. Drug Metabol. Dispos. 26:1998;989-992.
78. Santen R.J., Yue W., Naftolin F., Mor G., Berstein L. The potential of aromatase inhibitors in breast cancer prevention. Endocr. Relat. Cancer. 6:1999;235-243.
79. Santen R.J., Harvey H.A. Use of aromatase inhibitors in breast carcinoma. Endocr. Relat. Cancer. 6:1999;75-92.
80. Kao Y.C., Zhou C., Sherman M., Laughton C.A., Chen S. Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: a site-directed mutagenesis study. Environ. Health Perspect. 106:1998;85-92.
81. Prestera T., Zhang Y., Spencer S.R., Wilczak C.A., Tallay P. The electrophile counterattack response: protection against neoplasia and toxicity. Adv. Enzyme Regulat. 33:1993;281-296.
82. Wood A.W., Smith D.S., Chang R.L., Huang M.T., Conney A.H. Effects of flavonoids on the metabolism of xenobiotics. Prog. Clin. Biol. Res. 213:1986;195-210.
83. Siess M.H., Le Bon A.M., Suschetet M. Dietary modification of drug metabolizing enzyme activities: dose-response effect of flavonoids. J. Toxicol. Environ. Health. 35:1992;141-152.
84. Gulick A.M., Fahl W.E. Forced evolution of gluthathione S-transferase to create a more efficient drug detoxification enzyme. Proc. Natl. Acad. Sci. U.S.A. 92:1992;8140-8144.
85. Uda Y., Price K.R., Williamson G., Rhodes M.J. Induction of the anticarcinogenic marker enzyme, quinone reductase, in murine hepatoma cells in vitro by flavonoids. Cancer Lett. 120:1997;213-216.
86. Meisheri K.D., Johnson G.A., Puddington L. Enzymatic and non-enzymatic sulfation mechanisms in the biological actions of minoxidil. Biochem. Pharmacol. 45:1993;271-279.
87. Chou H.C., Lang N.P., Kadlubar F.F. Metabolic activation of N-hydroxy arylamines and N-hydroxy heterocyclic amines by human sulfotransferase(s). Cancer Res. 55:1995;525-529.
88. Eaton E.A., Walle U.K., Lewis A.J., Hudson T., Wilson A.A., Walle T. Flavonoids, potent inhibitors of the human P-form phenolsulfotransferase. Potential role in drug metabolism and chemoprevention. Drug Metabol. Dispos. 24:1996;232-237.
89. Phang J.M., Poore C.M., Lopaczynska J., Yeh G.C. Flavonol-stimulated efflux of 7,12-dimethylbenz[a]anthracene in multidrug-resistant breast cancer cells. Cancer Res. 53:1993;5977-5981.
90. Yeh G.C., Lopaczynska J., Poore C.M., Phang J.M. A new functional role for P-glycoprotein: efflux pump for benzo[a]pyrene in human breast cancer MCF-7 cells. Cancer Res. 52:1992;6692-6695.
91. LeBlanc G.A. Hepatic vectorial transport of xenobiotics. Chem. Biol. Interact. 90:1994;101-120.
92. Chieli E., Romiti N., Cervelli F., Tongiani R. Effects of flavonols on P-glycoprotein activity in cultured rat hepatocytes. Life Sci. 57:1995;1741-1751.
93. Critchfield J., Welsh C., Phang J., Yeh G. Modulation of adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells. Activation of P-glycoprotein as a putative mechanism. Biochem. Pharmacol. 48:1994;1437-1445.
94. O'Neil G.P., Ford-Hutchinson A.W. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett. 13:1993;156-160.
95. Williams C.S., DuBois R.N. Prostaglandin endoperoxide synthase: why two isoforms? Am. J. Physiol. 270:1996;G393-400.
96. Oshima M., Dinchuk J.E., Kargman S.L., Oshima H., Hancock B., Kwong E., Trzaskos J.M., Evans J.F., Taketo M.M. Suppression of intestinal polyposis in Apc delta-716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell. 87:1996;803-809.
97. Hida T., Kozaki K., Muramatsu H., Masuda A., Shimizu S., Mitsudomi T., Sugiura T., Ogawa M., Takahashi T. Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines. Clin. Cancer Res. 6:2000;2006-2011.
98. Gabor M., Razga Z. Effect of benzopyrone derivatives on simultaneously induced croton oil ear oedema and carrageenin paw oedema in rats. Acta Physiol. Hung. 77:1991;197-207.
99. Kang S.S., Kim J.S., Son K.H., Kim H.P., Chang H.W. Isolation of COX-2 inhibitors from Alpinia officinarum. Kor. J. Pharmacogn. 31:2000;57-62.
100. Kune G.A., Kune S., Watson L.F. Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study. Cancer Res. 48:1988;4399-4404.
101. Reddy B.S., Rao C.V., Seibert K. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res. 56:1996;4566-4569.
102. Schoenthal R. Carcinogenicity of N-methyl-N′-methyl-N-nitrosoguanidine. Cancer Res. 30:1966;455-465.
103. Shah G.M., Bhattacharya R.K. Modulation by plant flavonoids and related phenolics of microsome catalyzed adduct formation between benzo[a]pyrene and DNA. Chem. Biol. Interact. 59:1986;1-15.
104. Bhattacharya R.K., Firozi P.F. Effect of plant flavonoids on microsome catalyzed reactions of aflatoxin B1 leading to activation and DNA adduct formation. Cancer Lett. 39:1988;85-91.
105. Le Bon A.M., Siess M.H., Suschetet M. Inhibition of microsome-mediated binding of benzo[a]pyrene to DNA by flavonoids either in vitro or after dietary administration to rats. Chem. Biol. Interact. 83:1992;65-71.
106. Kim H.K., Heo M.Y., Kim H.P. Effects of antimutagenic flavonoid, galangin, on benzo[a]pyrene metabolism in mice. Kor. Biochem J. 24:1991;141-147.
107. Miller A.B. Diet and cancer: a review. Acta Oncol. 29:1990;87-95.
108. Halliwell B., Aruoma O.I. DNA damage by oxygen-derived species. Its mechanism and measurement in mammalian systems. FEBS Lett. 281:1991;9-19.
109. Floyd R.A. Role of oxygen free radicals in carcinogenesis and brain ischemia. FASEB J. 4:1990;2587-2597.
110. Kaneko T., Baba N. Protective effect of flavonoids on endothelial cells against linoleic acid hydroperoxide-induced toxicity. Biosci. Biotechnol. Biochem. 63:1999;323-328.
111. Husain S.R., Cillard J., Cillard P. Hydroxyl radical scavenging activity of flavonoids. Phytochemistry. 26:1987;2489-2491.
112. Robak J., Gryglewski R.J. Flavonoids are scavengers of superoxide anions. Biochem. Pharmacol. 37:1988;837-841.
113. Torel J., Cillard J., Cillard P. Antioxidant activity of flavonoids and reactivity with peroxyradical. Phytochemistry. 25:1986;383-385.
114. Chen Y., Zheng R., Jia Z., Ju Y. Flavonoids as superoxide scavengers and antioxidants. Free Radic. Biol. Med. 9:1990;19-21.
115. Bors W., Heller W., Michel C., Saran M. Flavonoids as antioxidants: determination of radical-scavenging efficiencies. Methods Enzymol. 186:1990;343-355.
116. Saija A., Scalese M., Lanza M., Marzullo D., Bonina F., Castelli F. Flavonoids as antioxidant agents: importance of their interaction with biomembranes. Free Radic. Biol. Med. 19:1995;481-486.
117. Hanasaki Y., Ogawa S., Fukui S. The correlation between active oxygens scavenging and antioxidative effects of flavonoids. Free Radic. Biol. Med. 16:1994;845-850.
118. Rice-Evans C.A., Miller N.J., Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic. Biol. Med. 20:1996;933-956.
119. Jung B.D., Kim C.H., Kim J.H., Heo M.Y. Protective effects of galangin on carbon tetrachloride-induced hepatotoxicity. Yakhak Hoeji. 40:1996;320-325.
120. van Acker S.A., van den Berg D.J., Tromp M.N., Griffioen D.H., van Bennekom W.P., van der Vijgh W.J., Blast A. Structural aspects of antioxidant activity of flavonoids. Free Radic. Biol. Med. 20:1996;331-342.
121. Myara I., Pico I., Vedie B., Moatti N. A method to screen for the antioxidant effect of compounds on low-density lipoprotein (LDL): illustration with flavonoids. J. Pharmacol. Toxicol. Methods. 30:1993;69-73.
122. Rapta P., Misik V., Stasko A., Vrabel I. Redox intermediates of flavonoids and caffeic acid esters from propolis: an EPR spectroscopy and cyclic voltammetry study. Free Radic. Biol. Med. 18:1995;901-908.
123. Hatch F.T., Lightstone F.C., Colvin M.E. Quantitative structure-activity relationship of flavonoids for inhibition of heterocyclic amine mutagenicity. Environ. Mol. Mutagen. 35:2000;279-299.
124. *1. Toxicology. 144:2000;31-38.
125. Edenharder R., von Petersdorff I., Rauscher R. Antimutagenic effects of flavonoids, chalcones and structurally related compounds on the activity of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and other heterocyclic amine mutagens from cooked food. Mutat. Res. 287:1993;261-274.
126. Edenharder R., Rauscher R., Platt K.L. The inhibition by flavonoids of 2-amino-3-methylimidazo[4,5-f]quinoline metabolic activation to a mutagen: a structure-activity relationship study. Mutat. Res. 379:1997;21-32.
127. Cotelle N., Bernier J.L., Catteau J.P., Pommery J., Wallet J.C., Gaydou E.M. Antioxidant properties of hydroxy-flavones. Free Radic. Biol. Med. 20:1996;35-43.
128. Knekt P., Jarvinen R., Seppanen R., Hellovaara M., Teppo L., Pukkala E., Aromaa A. Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am. J. Epidemiol. 146:1997;223-230.
129. Hertog M.G.L., Feskens E.J.M., Hollman P.C.H., Katan M.B., Kromhout D. Dietary of flavonoids and cancer risk in the Zutphen Eldery Study. Nutr. Cancer. 22:1994;175-184.
130. R.A. Goldbohm, P.A. van den Brandt, M.G.L. Hertog, H.A.A. Brants, G. Poppel, Flavonoid intake and risk of cancer: a prospective cohort study, Am. J. Epidemiol. 141 (Suppl.) (1995) s61 (Abstract).
131. Sugihara N., Arakawa T., Ohnishi M., Furuno K. Anti- and pro-oxidative effects of flavonoids on metal-induced lipid hydroperoxide-dependent lipid peroxidation in cultured hepatocytes loaded with alpha-linolenic acid. Free Radic. Biol. Med. 27:1999;1313-1323.
132. Heo M.Y., Kwon C.H., Sohn D.H., Lee S.J., Kim S.W., Kimand J.H., Au W.W. Effect of flavonol derivatives on the micronuclei formation by N-methyl-N′-nitro-N-nitrosoguanidine and the enhancement of bleomycin-induced chromosome aberration by N-methyl-N′-nitro-N-nitrosoguanidine. Arch. Pharm. Res. 16:1993;196-204.